-
The Upstream and Downstream products of 2-(Methylthio)-3-ethylpyrazine
Time of Update: 2023-05-09
Its ability to undergo a variety of chemical transformations makes it a valuable precursor to a variety of downstream products, including pharmaceuticals, agrochem In the chemical industry, one of the key factors that determines the profitability of a manufacturing process is the ability to produce high-value products.
-
The relationship between cardiovascular health and brain aging
Time of Update: 2023-02-03
The results adjusted for age, gender and education level are as follows:Good or moderate population CVH features are associated with slower progression of white matter hyperintensity (WMH) compared with poor overall CVH features.
-
Local ADC inventory: HER2, TROP2 are the most crowded, Hengrui, CSPC, Kelun, East China Medicine and other in-depth layout
Time of Update: 2023-01-05
(Incomplete statistics, if there is any error or omission of information, welcome to leave a message) Target homogenization is seriousHER2 and TROP2 are the most crowded Target clustering is a common phenomenon of global research and development, and this phenomenon is even more so in domestic ADC new drugs, according to statistics, 22 ADC drugs targeting the "number one target" HER2 have been announced in China, accounting for 26% of all products.
-
The most "hot" new crown oral drug Azvudine: the data has not yet been unblinded, and the second level has already been hyped
Time of Update: 2022-06-12
According to the statistics of Huachuang Pharmaceutical, as of now, there are 11 new crown oral drug projects in progress in China, and three in total in the third phase, namely Junshi's VV116, Kintor Pharmaceutical's Prokalutamide, and Real Biological of Azvudine .
-
Kelun Pharmaceutical's 2021 net profit will increase by 33% year-on-year
Time of Update: 2022-05-24
On April 10, Kelun Pharmaceutical released the 2021 performance report: the operating income in 2021 will be about 17.
103 billion yuan, a year-on-year increase of 32.
103 billion yuan, a year-on-year increase of 32.
78 yuan, a year-on-year increase of 34.
-
Domestic neutral borosilicate glass has huge potential space for upgrading, but there are still several problems to be solved
Time of Update: 2022-05-20
In the face of considerable potential space for upgrading, more and more domestic enterprises have joined the neutral borosilicate glass industry, and the entire pharmaceutical packaging industry has shown a thriving scene .
-
Hengrui Pharma Appoints New General Manager to Enhance Enterprise Transformation Momentum
Time of Update: 2022-05-13
On May 5, Hengrui Pharmaceutical announced that the company appointed Dai Hongbin as the general manager . This is the latest development of the adjustment of Hengrui Pharmaceutical's executive team
-
Industry: In March, it is recommended to pay attention to the oversold rebound in the pharmaceutical and biological sector
Time of Update: 2022-05-01
CITIC Construction Investment stated in the research report that after the previous adjustment and digestion, the pressure on the high valuation of the pharmaceutical sector has been gradually released, and the recent rebound is in line with expectations.
-
Sulfuric acid industry strives to ensure the supply of fertilizer raw materials for spring ploughing
Time of Update: 2022-04-24
During the peak fertilizer season, priority is given to ensuring the supply of sulfuric acid to phosphorus and compound fertilizer enterprises, and full horsepower is used to meet the needs of spring ploughing production .
-
The competition in the industry is becoming more and more fierce, and domestic medicine machines should not be in a hurry to "lie down
Time of Update: 2022-02-23
Since 2020, due to the impact of the epidemic, many imported equipment cannot be mass-produced in the short term due to the long delivery time, and pharmaceutical companies have turned to purchasing domestic pharmaceutical machines, which has brought opportunities for domestic pharmaceutical machinery and equipment, especially vaccine production equipment, and the number of orders has increased.
-
A large number of pharmaceutical companies have positive results, and the traditional Chinese medicine sector has performed well
Time of Update: 2022-01-22
According to the 2021 annual performance forecast released by Teyi Pharmaceutical on January 12, in 2021, Teyi Pharmaceutical is expected to have a net profit of 120 million yuan to 150 million yuan, a year-on-year increase of 173.
-
JAHA: The relationship between sleep awakening and hypertension in patients with obstructive sleep apnea
Time of Update: 2022-01-08
Repeated awakening during sleep is independently associated with the prevalence of hypertension in OSA patients .
Association Between Arousals During Sleep and Hypertension Among Patients With Obstructive Sleep Apnea .
-
In 2022, the wave of layoffs among multinational pharmaceutical companies is expected to continue
Time of Update: 2022-01-01
According to incomplete statistics in the industry, from January to November 2021, at least 28 multinational pharmaceutical companies have experienced layoffs, including Sanofi, Amgen, Gilead, Well-known large pharmaceutical companies such as Novartis, GlaxoSmithKline, Mylan, Gilead, Johnson & Johnson, and AstraZeneca .
-
Tens of billions of antithrombotic drugs have fallen into the "Altar"! TOP10 ranking changes
Time of Update: 2021-12-05
According to data from Meinenet, the market for terminal antithrombotic drugs in public medical institutions in China in 2021H1 increased by 13.
Ticagrelor tablets ranked sixth in the TOP10 terminal antithrombotic drug products of China's public medical institutions in 2020, and fell out of the top ten in 2021H1 .
-
Driven by innovation - Hollykangyuan fully automatic packaging solutions help the packaging industry to upgrade intelligently
Time of Update: 2021-11-15
Core technology accumulationIn order to promote the progress of the packaging industry in an all-round way, after years of scientific and technological innovation and core technology accumulation, Helixangyuan has realized accurate and stable drug dispensing, automatic adjustment of filling volume, touch terminal control, side film, rear discharge, and front opening in the field of automated packaging.
